Advertisement
Canagliflozin Coupon - Canagliflozin 300mg tablet
Canagliflozin

Invokana

Canagliflozin (Invokana) is an expensive drug used to treat type 2 diabetes. It helps to control blood sugar. This drug is more popular than comparable drugs. There are currently no generic alternatives to Invokana. It is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. The lowest GoodRx price for the most common version of Invokana is around $469.88, 18% off the average retail price of $573.82. Compare SGLT2 inhibitors.
Canagliflozin Coupon - Canagliflozin 300mg tablet

Insurance Coverage: Many major insurance plans no longer cover Invokana. Learn More

Canagliflozin Latest News

Get the latest updates on this drug from the GoodRx medical team

Save on Prescription Medications With Over 680 Copay Cards on GoodRx.com

Tori Marsh - August 16, 2018

Have you ever gone to the pharmacy only to realize that you’re on the hook for a high copay or your insurance just won’t cover your medication at all. You’re not alone. Luckily, many drug manufacturers offer savings through copay cards, also known as manufacturer coupons. These programs are typically for brand-name drugs, and can lower the price of your medication to as little as $0.

GoodRx currently has information on over 680 active copay cards for hundreds of prescription medications. See More

Prescription Drug Coupons: How to Use Pharmacy Discounts & Manufacturer Savings Cards

Roni Shye - August 10, 2018

You’re ready to pick up your prescription at the pharmacy. But how expensive will it be? And is there anything you can do to save money? Let’s discuss how to use pharmacy discount coupons and manufacturer savings cards to help you save on the medications you need.

First, what’s the difference between pharmacy discount coupons and manufacturer savings cards?

Pharmacy discount coupons

Pharmacy discount coupons, like the ones you’ll find on GoodRx. See More

Generic Jardiance Is 5 Years Away (At Least) — Here Are 5 Ways To Save Now

Tori Marsh - August 02, 2018

Well-known for treating type 2 diabetes, Jardiance can also reduce the risk of a cardiovascular event by 38%—but it’s expensive. A 30-day supply costs well over $500, and many insurance plans won’t cover it. Luckily, there are ways for you to save as much as 100% off the cash price.

How much does Jardiance cost?

As of August 2018, the cash price for Jardiance is over $500 for 30 tablets. GoodRx discounts can help reduce this price a bit—to around $450—but that’s still way too much for most people. See More

Here Are the 5 Best Ways To Save on Invokana, the Diabetes Drug

Tori Marsh - June 27, 2018

Let’s start with the bad news. Invokana, a tablet taken to treat type 2 diabetes, is really expensive. A 30-day supply of Invokana can cost around $550, and we may have to wait another six years to see a generic. But there is good news — there are ways to save.

Here’s all the information you need to make your Invokana prescription affordable.

How popular is Invokana?

Approved in 2013, Invokana is one of the most popular SGLT2 inhibitors, a class of drugs that is used to treat diabetes type 2 by blocking the kidneys from reabsorbing glucose so any excess is excreted from the body. See More

Why Taking Your Medications for These Common “Silent” Diseases is Important

Roni Shye - January 16, 2018

If you’ve ever been afraid to show up at your doctor’s office because you’ve been “bad” then this post is for YOU!  You may think your doctor is “pushing medications on you” especially if you aren’t experiencing any symptoms of the condition they are treating you for. However, their reasoning is not without sound medical and professional judgment. 

One of the many reasons you might receive a lecture about the importance of taking your medications is due to the progressive nature of many diseases if not properly treated. See More

Updated FDA Safety Alert: Invokana and Invokamet for Diabetes

Roni Shye - June 21, 2017

On May 16th, 2017, the FDA issued an update on canagliflozin-containing medications, like Invokana and Invokamet, as part of a year-long ongoing review.

This update is the result of new data from the CANVAS and CANVAS-R clinical trials. This research showed that leg and foot amputations occurred two times more often in patients treated with canagliflozin than in patients who were given a placebo sugar pill. See More

New FDA Safety Alert: Invokana and Farxiga for Diabetes

Roni Shye - July 06, 2016

In June 2016, the FDA issued a safety alert for canagliflozin (Invokana, Invokamet), used to treat type 2 diabetes.

Now, another warning has been issued, for Invokana and Invokamet along with another similar diabetes medication, dapagliflozin (Farxiga and Xigduo XR).

According to the FDA, canagliflozin and dapagliflozin may cause an increased risk of acute kidney injury. The previous warning for canagliflozin was for an increased risk of foot and leg amputations—all serious stuff. See More

FDA Safety Alert: Invokana and Invokamet for Diabetes

Roni Shye - June 08, 2016

The FDA has issued a safety alert for medications containing canagliflozin, a newer drug used to treat type 2 diabetes.

According to the FDA, medications containing canagliflozin (Invokana and Invokamet) may cause an increased risk of leg and foot amputations.

Do diabetics already have an increased risk of leg and foot amputations?

Yes. Diabetics have a higher risk of leg and foot amputations compared to a person who does not have diabetes. See More

50+ Drugs Dropped by Insurance in 2016, Including Viagra and Qsymia

Elizabeth Davis - August 12, 2015

It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.

Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
Safe Pharmacy